85085203 - LEADERSHIP IN NANOPHARMACEUTICALS

Information

• Trademark
• 85085203

• Source

• Serial Number

  85085203

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  July 15, 2010
  14 years ago

• Transaction Date

  March 17, 2014
  10 years ago

• Status Date

  March 17, 2014
  10 years ago

• Published for Opposition Date

  December 14, 2010
  14 years ago

• Location Date

  August 02, 2013
  11 years ago

• Status Code

  606

• Current Location

  INTENT TO USE SECTION

  Employee Name

  EVANKO, PATRICIA MALES

• Attorney Docket Number

  TPHA 1004940

  Attorney Name

  David Ehrlich

  Law Office Assigned Location Code

  N10

• Owners

  • Enumeral Biomedical Holdings, Inc.

Case File Statements

• D10000: "NANOPHARMACEUTICALS"
• GS0011: diagnostic and prognostic preparations for clinical or medical laboratory use; diagnostic and prognostic reagents for identifying a disease or disorder and/or the progression of a disease or disorder
• GS0051: Pharmaceutical preparations for use in the diagnosis and prognosis of oncological diseases or disorders; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of pre-cancerous diseases or disorders; pharmaceutical preparations for use in the diagnosis and prognosis of malignant cancers or neoplasms; pharmaceutical preparations for use in the diagnosis, prognosis and treatment of benign cancers or neoplasms; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of inflammation and inflammatory diseases or disorders; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of cardiovascular diseases or disorders; pharmaceutical preparations for use in modulating angiogenesis; pharmaceutical preparations, namely, drug delivery systems that contain compounds which facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical preparations, namely, drug delivery systems that contain nanometer scale or nanometer size compounds which facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical preparations, namely, drug delivery systems that contain polymer and/or lipid based compounds for controlled release of a wide range of pharmaceuticals; pharmaceutical preparations for use in the diagnosis and prognosis of oncological diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for use in the diagnosis, prognosis and treatment of pre-cancerous diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for use in the diagnosis, prognosis and treatment of benign cancers or neoplasms comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for use in the diagnosis and prognosis of malignant cancers or neoplasms comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of inflammation and inflammatory diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of cardiovascular diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical
• PM0000: LEADERSHIP IN NANO PHARMACEUTICALS

Case File Event Statements

• 3/17/2014 - 10 years ago

  41 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Type: MAB6

• 3/17/2014 - 10 years ago

  40 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 8/9/2013 - 11 years ago

  39 - NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Type: EXRA

• 8/8/2013 - 11 years ago

  38 - EXTENSION 5 GRANTED Type: EX5G

• 7/9/2013 - 11 years ago

  37 - EXTENSION 5 FILED Type: EXT5

• 8/2/2013 - 11 years ago

  36 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 7/9/2013 - 11 years ago

  35 - TEAS EXTENSION RECEIVED Type: EEXT

• 1/30/2013 - 12 years ago

  34 - NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Type: EXRA

• 1/29/2013 - 12 years ago

  33 - EXTENSION 4 GRANTED Type: EX4G

• 1/10/2013 - 12 years ago

  32 - EXTENSION 4 FILED Type: EXT4

• 1/10/2013 - 12 years ago

  31 - TEAS EXTENSION RECEIVED Type: EEXT

• 9/5/2012 - 12 years ago

  30 - NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Type: EXRA

• 9/5/2012 - 12 years ago

  29 - CORRECTED NOA MAILED Type: NOAC

• 9/4/2012 - 12 years ago

  28 - EXTENSION 3 GRANTED Type: EX3G

• 7/24/2012 - 12 years ago

  27 - EXTENSION 3 FILED Type: EXT3

• 9/4/2012 - 12 years ago

  26 - DIVISIONAL PROCESSING COMPLETE Type: DPCC

• 7/24/2012 - 12 years ago

  25 - DIVISIONAL REQUEST RECEIVED Type: DRRR

• 7/24/2012 - 12 years ago

  24 - TEAS REQUEST TO DIVIDE RECEIVED Type: ERTD

• 7/24/2012 - 12 years ago

  23 - TEAS EXTENSION RECEIVED Type: EEXT

• 3/7/2012 - 13 years ago

  22 - NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Type: EXRA

• 3/6/2012 - 13 years ago

  21 - EXTENSION 2 GRANTED Type: EX2G

• 2/8/2012 - 13 years ago

  20 - EXTENSION 2 FILED Type: EXT2

• 3/2/2012 - 13 years ago

  19 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 2/8/2012 - 13 years ago

  18 - TEAS EXTENSION RECEIVED Type: EEXT

• 7/28/2011 - 13 years ago

  17 - NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Type: EXRA

• 7/26/2011 - 13 years ago

  16 - EXTENSION 1 GRANTED Type: EX1G

• 7/26/2011 - 13 years ago

  15 - EXTENSION 1 FILED Type: EXT1

• 7/26/2011 - 13 years ago

  14 - TEAS EXTENSION RECEIVED Type: EEXT

• 2/8/2011 - 14 years ago

  13 - NOA MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 12/14/2010 - 14 years ago

  12 - PUBLISHED FOR OPPOSITION Type: PUBO

• 11/24/2010 - 14 years ago

  11 - NOTICE OF PUBLICATION Type: NPUB

• 11/10/2010 - 14 years ago

  10 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 11/10/2010 - 14 years ago

  9 - ASSIGNED TO LIE Type: ALIE

• 10/29/2010 - 14 years ago

  8 - EXAMINER'S AMENDMENT MAILED Type: CNEA

• 10/28/2010 - 14 years ago

  7 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 10/28/2010 - 14 years ago

  6 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 10/28/2010 - 14 years ago

  5 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 10/28/2010 - 14 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 7/21/2010 - 14 years ago

  3 - NOTICE OF PSEUDO MARK MAILED Type: MPMK

• 7/20/2010 - 14 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 7/19/2010 - 14 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP